T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CON
326
Concentra Group Holdings
CON
$4.48B
| $343M | 0.04% |
17,340,387
+14,188,333
| +450% | +$293M |
|
327
Southern Copper
SCCO
$158B
| $337M | 0.04% |
3,953,266
-8,348
| -0.2% | -$824K |
|
328
RTX Corp
RTX
$297B
| $334M | 0.04% |
2,890,454
-438,761
| -13% | -$53M |
|
329
Enbridge
ENB
$112B
| $332M | 0.04% |
7,831,628
-3,161,649
| -29% | -$132M |
|
|
SEM
330
DELISTED
Select Medical
SEM
| $330M | 0.04% |
17,484,810
-15,023,104
| -46% | -$290M |
|
331
Bath & Body Works
BBWI
$3.76B
| $329M | 0.04% |
8,494,089
+445,887
| +6% | +$14.9M |
|
332
Gilead Sciences
GILD
$171B
| $328M | 0.04% |
3,546,721
+198,528
| +6% | +$17.9M |
|
333
Wingstop
WING
$3.1B
| $327M | 0.04% |
1,150,217
+262,229
| +30% | +$89.1M |
|
334
American Homes 4 Rent
AMH
$12.3B
| $326M | 0.04% |
8,721,356
+675,077
| +8% | +$25.3M |
|
335
Vaxcyte
PCVX
$8.76B
| $325M | 0.04% |
3,966,956
-499,181
| -11% | -$49.6M |
|
336
Cooper Companies
COO
$14.9B
| $324M | 0.04% |
3,529,477
+2,957,421
| +517% | +$301M |
|
337
StepStone Group
STEP
$4.28B
| $324M | 0.04% |
5,599,875
+895,521
| +19% | +$55.5M |
|
338
Constellation Brands
STZ
$23.3B
| $324M | 0.04% |
1,465,075
-55,747
| -4% | -$13.2M |
|
|
EXAS
339
DELISTED
Exact Sciences
EXAS
| $324M | 0.04% |
5,760,241
+2,462,165
| +75% | +$153M |
|
|
RNAM
340
DELISTED
Avidity Biosciences
RNAM
| $321M | 0.04% |
11,042,823
+408,861
| +4% | +$17.1M |
|
341
Advance Auto Parts
AAP
$3.46B
| $316M | 0.04% |
6,685,541
+1,706,328
| +34% | +$69.5M |
|
342
Voya Financial
VOYA
$9.16B
| $316M | 0.04% |
4,584,390
-96,407
| -2% | -$7.53M |
|
343
Ascendis Pharma A/S
ASND
$16.2B
| $314M | 0.04% |
2,283,207
+162,079
| +8% | +$21.3M |
|
344
Royal Caribbean
RCL
$82.9B
| $309M | 0.04% |
1,340,619
-152,377
| -10% | -$33.7M |
|
345
Western Union
WU
$2.34B
| $307M | 0.04% |
28,983,265
+4,426,126
| +18% | +$49M |
|
346
Motorola Solutions
MSI
$77B
| $307M | 0.04% |
664,185
-41,729
| -6% | -$19.8M |
|
347
Target
TGT
$70.6B
| $302M | 0.03% |
2,232,776
-353,988
| -14% | -$50.7M |
|
348
Dover
DOV
$27.8B
| $302M | 0.03% |
1,607,392
-2,063,308
| -56% | -$403M |
|
349
Vale
VALE
$58.7B
| $302M | 0.03% |
33,995,398
+5,775,590
| +20% | +$58.8M |
|
350
Penumbra
PEN
$12.9B
| $301M | 0.03% |
1,265,687
-719,571
| -36% | -$164M |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.